BioCentury
ARTICLE | Finance

Strategic investing in China

The inner workings of TVM's China fund

June 22, 2015 7:00 AM UTC

With one strategic investor signed up and a proof-of-principle deal in place, TVM Capital Life Science hopes to recruit up to two more Chinese companies to invest in its China BioPharma Capital I fund.

The formula, said TVM's Mirko Scherer, is to "invest in Western companies, take an equity stake and then bring a Chinese license to our strategic investor. We don't claim, TVM itself, to be a China expert, but we have a partner that brings the expertise to the table. Our partner knows the regulatory system and how to market in China." ...